EP2097749A4 - Assay for cardiac troponin autoantibodies - Google Patents

Assay for cardiac troponin autoantibodies

Info

Publication number
EP2097749A4
EP2097749A4 EP07871173A EP07871173A EP2097749A4 EP 2097749 A4 EP2097749 A4 EP 2097749A4 EP 07871173 A EP07871173 A EP 07871173A EP 07871173 A EP07871173 A EP 07871173A EP 2097749 A4 EP2097749 A4 EP 2097749A4
Authority
EP
European Patent Office
Prior art keywords
assay
cardiac troponin
troponin autoantibodies
autoantibodies
cardiac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07871173A
Other languages
German (de)
French (fr)
Other versions
EP2097749A2 (en
Inventor
Phillip G Mattingly
Maciej Adamczyk
Roy Jeffrey Brashear
Robert C Doss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of EP2097749A2 publication Critical patent/EP2097749A2/en
Publication of EP2097749A4 publication Critical patent/EP2097749A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
EP07871173A 2006-10-26 2007-10-17 Assay for cardiac troponin autoantibodies Withdrawn EP2097749A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/588,073 US7776605B2 (en) 2006-10-26 2006-10-26 Assay for cardiac troponin autoantibodies
PCT/US2007/081606 WO2008051761A2 (en) 2006-10-26 2007-10-17 Assay for cardiac troponin autoantibodies

Publications (2)

Publication Number Publication Date
EP2097749A2 EP2097749A2 (en) 2009-09-09
EP2097749A4 true EP2097749A4 (en) 2009-12-30

Family

ID=39325249

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07871173A Withdrawn EP2097749A4 (en) 2006-10-26 2007-10-17 Assay for cardiac troponin autoantibodies

Country Status (6)

Country Link
US (4) US7776605B2 (en)
EP (1) EP2097749A4 (en)
JP (1) JP2010508515A (en)
CA (1) CA2666586A1 (en)
MX (1) MX2009004463A (en)
WO (1) WO2008051761A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070172888A1 (en) * 2006-01-25 2007-07-26 Klaus Hallermayer Measuring troponin antibodies to assess cardiovascular risk
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
WO2008051762A2 (en) * 2006-10-26 2008-05-02 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
US8420330B2 (en) 2011-07-15 2013-04-16 Myra A. Lipes Diagnosis and treatment of cardiac troponin 1 (cTn1) autoantibody-mediated heart disease
US8278057B2 (en) 2007-09-14 2012-10-02 Nestec S.A. Addressable antibody arrays and methods of use
WO2009118185A1 (en) * 2008-03-27 2009-10-01 Universitätsklinikum Heidelberg Peptides derived from cardial troponin i and their use as prognostic and diagnostic markers for heart failure
US20090286329A1 (en) * 2008-05-19 2009-11-19 Abbott Laboratoires Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
US20090286256A1 (en) * 2008-05-19 2009-11-19 Abbott Laboratories Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
CA2754980A1 (en) * 2009-03-18 2010-09-23 Prometheus Laboratories Inc. Addressable antibody arrays and methods of use
US8652788B2 (en) * 2009-12-02 2014-02-18 Abbott Laboratories Assay for diagnosis of cardiac myocyte damage
US8835120B2 (en) * 2009-12-02 2014-09-16 Abbott Laboratories Assay for cardiac troponin-T (cTnT)
US20110136141A1 (en) * 2009-12-03 2011-06-09 Abbott Laboratories Peptide reagents and method for inhibiting autoantibody antigen binding
EP2517015A1 (en) * 2009-12-23 2012-10-31 Koninklijke Philips Electronics N.V. Analyte measurement apparatus and method
EP2580593A4 (en) * 2010-06-10 2014-04-16 Myra Lipes Diagnosis of myocardial autoimmunity in heart disease
US20110306148A1 (en) 2010-06-14 2011-12-15 Siemens Healthcare Diagnostics Inc. Composition for use as an assay reagent
US20130121998A1 (en) * 2010-06-16 2013-05-16 Myra A. Lipes Diagnosis of Myocardial Autoimmunity in Heart Disease
WO2014097877A1 (en) * 2012-12-19 2014-06-26 コニカミノルタ株式会社 Sensor chip and spfs immunofluorescence measurement system
US10670611B2 (en) 2014-09-26 2020-06-02 Somalogic, Inc. Cardiovascular risk event prediction and uses thereof
EP3634528B1 (en) 2017-06-07 2023-06-07 Shifamed Holdings, LLC Intravascular fluid movement devices, systems, and methods of use
EP3477300A1 (en) * 2017-10-25 2019-05-01 Euroimmun Medizinische Labordiagnostika AG Cellulose-based immunoadsorber
CN111556763B (en) 2017-11-13 2023-09-01 施菲姆德控股有限责任公司 Intravascular fluid movement device and system
JP7410034B2 (en) 2018-02-01 2024-01-09 シファメド・ホールディングス・エルエルシー Intravascular blood pump and methods of use and manufacture
WO2021016372A1 (en) 2019-07-22 2021-01-28 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
EP4034192A4 (en) 2019-09-25 2023-11-29 Shifamed Holdings, LLC Intravascular blood pump systems and methods of use and control thereof
CN112526140A (en) * 2020-11-16 2021-03-19 北京利德曼生化股份有限公司 Magnetic particle chemiluminescence detection kit for determining content of hypersensitive troponin T

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007085411A1 (en) * 2006-01-25 2007-08-02 Roche Diagnostics Gmbh Anti-troponin antibodies and cardiovascular risk

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (en) 1970-11-10 1977-09-15 Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING LOW MOLECULAR COMPOUNDS AND PROTEINS THAT CAN SPECIFICALLY BIND THESE COMPOUNDS AND TEST PACKAGING.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4637880A (en) * 1981-11-30 1987-01-20 Cordis Laboratories, Inc. Apparatus and method for therapeutic immunodepletion
ATE111083T1 (en) 1986-10-22 1994-09-15 Abbott Lab CHEMILUMINESCENT ACRIDINIUM AND PHENANTRIDINIUM SALTS.
US5132405A (en) 1987-05-21 1992-07-21 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
JPS6412935A (en) 1987-07-02 1989-01-17 Mitsubishi Electric Corp Constant-speed travel device for vehicle
AU609241B2 (en) 1988-01-29 1991-04-26 Abbott Laboratories Ion-capture assays and devices
US5006309A (en) 1988-04-22 1991-04-09 Abbott Laboratories Immunoassay device with liquid transfer between wells by washing
US5244630A (en) 1988-04-22 1993-09-14 Abbott Laboratories Device for performing solid-phase diagnostic assay
US5089424A (en) 1988-06-14 1992-02-18 Abbott Laboratories Method and apparatus for heterogeneous chemiluminescence assay
US5063081A (en) 1988-11-14 1991-11-05 I-Stat Corporation Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor
WO1990012852A1 (en) 1989-04-14 1990-11-01 Procedes Petroliers Et Petrochimiques Process for steam-cracking hydrocarbons
CA1341592C (en) 1989-07-07 2009-04-14 Abbott Laboratories Ion capture reagents and methods for performing binding assays
EP0651253A1 (en) * 1993-11-02 1995-05-03 Abbott Laboratories Immunoassay for the detection of human autoantibodies
US5534615A (en) * 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US5561049A (en) * 1994-09-21 1996-10-01 Behringwerke Ag Method for detecting antibodies
US6174686B1 (en) * 1995-04-18 2001-01-16 Biosite Diagnostics, Inc. Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays
US5795725A (en) * 1995-04-18 1998-08-18 Biosite Diagnostics Incorporated Methods for the assay of troponin I and T and selection of antibodies for use in immunoassays
US5981180A (en) * 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US7285418B2 (en) * 1996-06-25 2007-10-23 Hytest Ltd. Method and kit for the diagnosis of troponin I
DE19651093C2 (en) * 1996-12-09 1999-06-10 Brahms Diagnostica Gmbh Receptor binding assay for the detection of TSH receptor autoantibodies and set of reagents for performing such a receptor binding assay
US6682648B1 (en) 1997-08-12 2004-01-27 University Of Southern California Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures
US6303325B1 (en) 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes
US6294062B1 (en) 1998-06-01 2001-09-25 Roche Diagnostics Corporation Method and device for electrochemical immunoassay of multiple analytes
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
US6645465B2 (en) * 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
WO2001038873A2 (en) 1999-11-24 2001-05-31 Biotronic Technologies, Inc. Devices and methods for detecting analytes using electrosensor having capture reagent
US20040248216A1 (en) 2000-03-30 2004-12-09 Yuko Seino Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor
EP1149914B1 (en) 2000-04-10 2008-06-18 Labor Dr. Merk und Kollegen GmbH A fusion protein that recognizes human autoantibodies simultaneously
FR2810739B1 (en) 2000-06-26 2007-01-26 Centre Nat Rech Scient ELECTROCHEMICAL IMMUNODOSIS USING COLLOIDAL METAL MARKERS
GB0017641D0 (en) * 2000-07-18 2000-09-06 Medigene Oy Peptides and their use
US6887714B2 (en) 2000-10-16 2005-05-03 Board Of Trustees Of The University Of Arkansas, N.A. Microvolume immunoabsorbant assays with amplified electrochemical detection
JP4309758B2 (en) * 2001-05-25 2009-08-05 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド Antibodies that immunospecifically bind to TRAIL receptors
US6896872B2 (en) * 2001-06-27 2005-05-24 Svetlana A. Dambinova Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke
WO2003016575A1 (en) 2001-08-17 2003-02-27 Luminex Corporation Method for characterizing autoimmune disorders
US20030100036A1 (en) * 2001-11-08 2003-05-29 Aristo Vojdani Saliva immunoassay for detection of antibodies for cardiovascular disease
US7419821B2 (en) 2002-03-05 2008-09-02 I-Stat Corporation Apparatus and methods for analyte measurement and immunoassay
US20040018577A1 (en) 2002-07-29 2004-01-29 Emerson Campbell John Lewis Multiple hybrid immunoassay
US7196169B2 (en) * 2002-10-11 2007-03-27 Queen's University At Kingston Isolated post-translationally modified mammalian proteins for monitoring and diagnosing muscle damage
ATE494549T1 (en) * 2003-04-16 2011-01-15 Ono Pharmaceutical Co SCREENING METHOD FOR HEART DISEASE CURE AND MEDICAL COMPOSITION FOR TREATING HEART DISEASE
FI20030652A0 (en) * 2003-04-30 2003-04-30 Susann Eriksson Improved immune determination
US6924373B2 (en) * 2003-05-02 2005-08-02 Asiagen Corporation DNA labeling reagents, acridinium-9-carboxamide derivatives and process of preparing DNA labeling compounds
US7723099B2 (en) 2003-09-10 2010-05-25 Abbott Point Of Care Inc. Immunoassay device with immuno-reference electrode
US7682833B2 (en) 2003-09-10 2010-03-23 Abbott Point Of Care Inc. Immunoassay device with improved sample closure
JP4711963B2 (en) * 2003-09-15 2011-06-29 オクラホマ メディカル リサーチ ファウンデーション Methods using cytokine assays to diagnose, treat and evaluate inflammatory and autoimmune diseases
US20050181451A1 (en) * 2004-02-12 2005-08-18 Bates Harold M. Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants
US7279281B2 (en) * 2004-06-01 2007-10-09 The Regents Of The University Of Michigan Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases
US20060024744A1 (en) * 2004-07-28 2006-02-02 Mills Rhonda A Methods for substantially simultaneous evaluation of a sample containing a cellular target and a soluble analyte
SE0402536D0 (en) 2004-10-20 2004-10-20 Therim Diagnostica Ab Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
US7291854B2 (en) 2005-07-18 2007-11-06 Trinity Health Corporation Radiation attenuation corridor
US20070172888A1 (en) * 2006-01-25 2007-07-26 Klaus Hallermayer Measuring troponin antibodies to assess cardiovascular risk
US20080305512A1 (en) 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
WO2008051762A2 (en) 2006-10-26 2008-05-02 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
US7776605B2 (en) 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007085411A1 (en) * 2006-01-25 2007-08-02 Roche Diagnostics Gmbh Anti-troponin antibodies and cardiovascular risk

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ADAMCZYK, M., ET AL: "Circulating Cardiac Troponin-I Autoantibodies in Human Plasma and Serum", CONTEMPORARY CHALLENGES IN AUTOIMMUNITY, vol. 1173, 2009, pages 67 - 74, XP002556066 *
ERIKSSON S ET AL: "Autoantibodies against cardiac troponins", NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, BOSTON, MA, US, vol. 352, no. 1, 6 January 2005 (2005-01-06), pages 98 - 100, XP008060221, ISSN: 1533-4406 *
ERIKSSON, S., ET AL: "Comparison of Cardiac Troponin I Immunoassays Variably Affected by Circulating Autoantibodies", CLINICAL CHEMISTRY, vol. 51, no. 5, 2005, pages 848 - 855, XP002556065 *
ERIKSSON, S., ET AL: "Negative Interference in Cardiac Troponin I Immunoassays by Circulating Troponin Autoantibodies", CLINICAL CHEMISTRY, vol. 51, no. 5, 2005, pages 839 - 847 *
See also references of WO2008051761A2 *
SHMILOVICH ET AL: "Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy", INTERNATIONAL JOURNAL OF CARDIOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 117, no. 2, 2 August 2006 (2006-08-02), pages 198 - 203, XP022000067, ISSN: 0167-5273 *

Also Published As

Publication number Publication date
US20120302458A1 (en) 2012-11-29
CA2666586A1 (en) 2008-05-02
US20100311079A1 (en) 2010-12-09
EP2097749A2 (en) 2009-09-09
WO2008051761A2 (en) 2008-05-02
JP2010508515A (en) 2010-03-18
US8173382B2 (en) 2012-05-08
US7776605B2 (en) 2010-08-17
WO2008051761A3 (en) 2008-11-13
US20090017560A1 (en) 2009-01-15
MX2009004463A (en) 2009-05-08
US20080102481A1 (en) 2008-05-01

Similar Documents

Publication Publication Date Title
EP2097749A4 (en) Assay for cardiac troponin autoantibodies
IL194892A0 (en) Nonseparation assay methods
DE602006010048D1 (en) Biosensor
EP2021778A4 (en) Nonseparation assay methods
GB0705495D0 (en) Whole blood assay
IL196268A0 (en) Assay methods
GB0723338D0 (en) Prognostic assay
GB0519605D0 (en) Assay
GB0608446D0 (en) Assay
GB0600031D0 (en) Assay
GB0615813D0 (en) Assay
GB0502065D0 (en) Assay method
GB0623892D0 (en) Assay
GB0607462D0 (en) Assay
GB0720672D0 (en) Assay method
GB0511279D0 (en) Assay
GB0503741D0 (en) Assay
GB0600810D0 (en) Assay
GB0618486D0 (en) Assay
GB0609175D0 (en) Assay
GB0602241D0 (en) Assay
GB0621829D0 (en) Assay
GB0625379D0 (en) Assay
GB0604978D0 (en) Assay
GB0601964D0 (en) Assay

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090526

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20091202

17Q First examination report despatched

Effective date: 20100208

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/68 20060101ALI20140113BHEP

Ipc: G01N 33/543 20060101AFI20140113BHEP

Ipc: G01N 33/564 20060101ALI20140113BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20140305

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140716